CANNASEN®CBD Anti-Hair Loss serum has been successfully approved in the United Arab Emirates
CS MEDICA A/S (”CS MEDICA” or the ”Company”) announces today that CanNordic a/s (“CanNordic”) and CANNASEN® CBD has been chosen as one of the participants in the Vitafoods Europe 2022 Innovation Tours after being considered as one of the most innovative companies with unique, cutting-edge ingredients, formulations, products, and services.
As an exhibitor at Vitafoods Europe 2022 and after submitting the Company’s market innovation details, CanNordic was successfully selected to take part in the Vitafoods Europe 2022 Innovation Tours. CanNordic will participate in the Vitafoods Europe event to showcase the truly innovative CANNASEN ®CBD line. Vitafoods Europe is an annual gathering covering the entire nutraceutical supply chain where businesses can establish long-term collaborations and contribute to conversations around issues in the health and nutrition industry.
The Vitafoods Europe 2022 Innovation Tours will consist of a series of video tours that will highlight the most unique, cutting-edge ingredients, formulations, products, and services. To showcase the innovations effectively to the audience, the Vitafoods Europe 2022 Innovation Tours will be hosted on an online platform prior to the in-person show dates. Vitafoods Europe 2022 will be a hybrid event and will be available online 2-13 May 2022 and the in-person event will take place 10-12 May 2022. The digital offering is meant to help the global attendees uncover the unique offerings at the event, including CS MEDICA.
CanNordic will be highlighted in the Innovation Tour video where a member of the Vitafoods content team will introduce CanNordic and the CANNASEN ®CBD line. The Innovation Tour video will also include a recorded video from a CanNordic representative answering three questions: 1) What is this new innovative offering, and what differentiates it from similar products? 2) How does this product address specific industry and/or consumer needs? 3) What testing and research supports this product?
CanNordic will also be listed on the Innovation Tour landing page along with the Company logo, booth number for the in-person event, and hyperlink to the Virtual Booth. This will enable attendees to ask for more information or book a meeting with CanNordic representatives.
For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.
The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.